We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
US-based BostonGene Corporation has announced a major research collaboration with Mater Research to discover novel diagnostic biomarkers of follicular lymphoma and ...
When Queensland musician and fitness influencer Shelley Bishop received the shocking news she had cancer, it was her friend, Australian pop princess Delta Goodrem ...
It is estimated over 110 000 people are living with blood cancer or a related blood disorder in Australia today and sadly 15 people lose their life to blood cancer ...
Mater Researcher and clinician-scientist, Dr Joshua Tobin has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award.
During a world first therapy conducted at the Princess Alexandra Hospital by Mater Researcher and Haematologist Professor Maher Gandhi a 46-year-old patient Scott ...
Today on World Lymphoma Awareness Day the staff of wards 8 East and North at Mater Private Hospital Brisbane dressed in lime to raise awareness of lymphoma symptoms ...
Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with ...
More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.